|By Marketwired .||
|January 9, 2014 02:47 PM EST||
SALINAS, CA -- (Marketwired) -- 01/09/14 -- Next Pharmaceuticals has begun administering all Sytrinol sales as of January 1, 2014 after purchasing worldwide distribution rights, along with all patents, trademarks and scientific knowledge from KGK Synergize in May 2013. Sytrinol is an all-natural dietary supplement for support of healthy cholesterol levels and Next Pharmaceuticals' newest addition to the company's portfolio of patented, science-based products.
Sytrinol is a proven, proprietary formula derived from natural citrus and palm fruit extracts, combining polymethoxylated flavones (PMFs) and tocotrienols from premier suppliers. Sytrinol has been granted self-affirmed GRAS (Generally Recognized as Safe) status and is now Kosher certified.
Clinical research has demonstrated that Sytrinol significantly aids in improving total cholesterol, LDLCholesterol, and triglycerides up to 30%, 27%, and 34%, respectively, compared to placebo. Sytrinol has also been shown to increase HDLCholesterol.
The results of all Sytrinol studies are now clearly presented on Next Pharmaceutical's website, with visuals to support findings. The website also provides locations where Sytrinol is available for purchase.
"Sytrinol is an effective, all-natural ingredient, and we are happy to include it in our line of patented, branded products", said Regan Miles, President of Next Pharmaceuticals. "We look forward to expanding Sytrinol in the market and helping to make it available for those who may benefit from its use."
Founded in 1997, Next Pharmaceuticals provides patented, science based natural ingredients for healthy living products in the dietary supplement, food and beverage industries. Next has successfully developed six patented and proprietary plant extracts in addition to Chromulin®, a new, safer form of the essential trace mineral chromium.
Next products help consumers cope with many of today's most prevalent and chronic health issues, significantly expanding the choices for selfcare products while providing customer brands with powerful product differentiation.
Next proprietary formulations include Sytrinol® for balanced cholesterol, Relora® for stress, stressrelated eating and weight management; Seditol® for improved, more restful sleep; Nexrutine® for joint discomfort due to overexertion and exercise; CitriZ® for heart health; Citrofen® for joint mobility and comfort; and Chromulin® for balanced blood sugar and optimum metabolism.
For more information on Next Pharmaceuticals and its ingredients, including Sytrinol, visit www.NextPharmaceuticals.com.
Environmental Relations PR